• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑白质和灰质多发性硬化病灶中的 microRNAs:对病理生理学的影响。

MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiology.

机构信息

Institute of Neuropathology, University Hospital Essen, Essen, Germany.

Institute of Clinical Neuroimmunology, Ludwig-Maximilians-Universität München, Munich, Germany.

出版信息

J Pathol. 2020 Apr;250(5):496-509. doi: 10.1002/path.5399. Epub 2020 Mar 5.

DOI:10.1002/path.5399
PMID:32073139
Abstract

Multiple sclerosis (MS) is a chronic disease of the CNS, hallmarked by inflammation and demyelination. Early stages of the disease frequently show active lesions containing numerous foamy macrophages and inflammatory cells. Disease progression is highlighted by increasing numbers of mixed active/inactive or inactive lesions showing sparse inflammation and pronounced astrogliosis. Furthermore, gray matter lesions increase in number and extent during disease progression. MicroRNAs (miRNAs) comprise a group of several thousand (in humans more than 2000), small non-coding RNA molecules with a fundamental influence on about one-third of all protein-coding genes. Furthermore, miRNAs have been detected in body fluids, including spinal fluid, and they are assumed to participate in intercellular communications. Several studies have determined miRNA profiles from dissected white and gray matter lesions of autoptic MS patients. In this review, we summarize in detail the current knowledge of individual miRNAs in gray and white matter lesions of MS patients and present the concepts of MS tissue lesion development based on the altered miRNA profiles. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

摘要

多发性硬化症(MS)是一种中枢神经系统的慢性疾病,其特征是炎症和脱髓鞘。疾病的早期阶段常出现含有大量泡沫状巨噬细胞和炎症细胞的活跃病变。疾病的进展以混合活跃/不活跃或不活跃病变的数量增加为特征,这些病变表现出稀疏的炎症和明显的星形胶质增生。此外,在疾病进展过程中,灰质病变的数量和范围增加。microRNAs(miRNAs)是一组几千个(在人类中超过 2000 个)的小非编码 RNA 分子,对大约三分之一的蛋白质编码基因具有根本影响。此外,miRNAs 已在包括脑脊液在内的体液中被检测到,它们被认为参与细胞间通讯。几项研究已经确定了来自尸检 MS 患者白质和灰质病变中分离的 miRNA 图谱。在这篇综述中,我们详细总结了 MS 患者灰质和白质病变中个别 miRNAs 的最新知识,并根据改变的 miRNA 图谱提出了 MS 组织病变发展的概念。©2020 作者。The Journal of Pathology 由 John Wiley & Sons Ltd 代表英国和爱尔兰的病理学会出版。

相似文献

1
MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiology.脑白质和灰质多发性硬化病灶中的 microRNAs:对病理生理学的影响。
J Pathol. 2020 Apr;250(5):496-509. doi: 10.1002/path.5399. Epub 2020 Mar 5.
2
[Gray matter lesions and cognitive impairment in multiple sclerosis].[多发性硬化症中的灰质病变与认知障碍]
Rinsho Shinkeigaku. 2014;54(12):1060-2. doi: 10.5692/clinicalneurol.54.1060.
3
Astrocytes in the Pathogenesis of Multiple Sclerosis: An In Situ MicroRNA Study.多发性硬化症发病机制中的星形胶质细胞:原位 microRNA 研究。
J Neuropathol Exp Neurol. 2019 Dec 1;78(12):1130-1146. doi: 10.1093/jnen/nlz098.
4
Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment.调控小胶质细胞 TMEM119 和 P2RY12 免疫反应在多发性硬化症白质和灰质病灶中的依赖于它们的炎症环境。
Acta Neuropathol Commun. 2019 Dec 11;7(1):206. doi: 10.1186/s40478-019-0850-z.
5
Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.组织驻留记忆 T 细胞浸润多发性硬化症白质病变的脑组织。
Brain. 2020 Jun 1;143(6):1714-1730. doi: 10.1093/brain/awaa117.
6
Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis.多发性硬化症慢性活动性和软脑膜下灰质病变边缘的小胶质细胞/巨噬细胞转录谱。
Ann Neurol. 2024 May;95(5):907-916. doi: 10.1002/ana.26877. Epub 2024 Feb 12.
7
Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.小热休克蛋白在多发性硬化症病变发展过程中于白质而非灰质中被诱导产生。
Acta Neuropathol Commun. 2015 Dec 22;3:87. doi: 10.1186/s40478-015-0267-2.
8
MicroRNA profiles of MS gray matter lesions identify modulators of the synaptic protein synaptotagmin-7.多发性硬化症灰质病变的 microRNA 谱可识别突触蛋白 synaptotagmin-7 的调节剂。
Brain Pathol. 2020 May;30(3):524-540. doi: 10.1111/bpa.12800. Epub 2019 Nov 17.
9
Acute and chronic synaptic pathology in multiple sclerosis gray matter.多发性硬化症灰质中的急性和慢性突触病理学
Mult Scler. 2022 Mar;28(3):369-382. doi: 10.1177/13524585211022174. Epub 2021 Jun 14.
10
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.多发性硬化症深部灰质:脱髓鞘、神经退行性变、炎症与铁之间的关系
J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1386-95. doi: 10.1136/jnnp-2014-307712. Epub 2014 Jun 4.

引用本文的文献

1
Association of Epistatic Effects of lncRNA GAS5, miR-146a, IRAK-1, and miR-155 Genetic Variants with Multiple Sclerosis Risk and Severity.lncRNA GAS5、miR-146a、IRAK-1和miR-155基因变异的上位性效应与多发性硬化症风险及严重程度的关联
Mol Neurobiol. 2025 Apr 15. doi: 10.1007/s12035-025-04876-8.
2
Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.通过多组学和基于网络的方法理解潜在生物标志物在减缓多发性硬化症进展中的作用。
PLoS One. 2024 Dec 19;19(12):e0314428. doi: 10.1371/journal.pone.0314428. eCollection 2024.
3
AKRs confer oligodendrocytes resistance to differentiation-stimulated ferroptosis.
醛酮还原酶赋予少突胶质细胞对分化刺激引起的铁死亡的抗性。
Redox Biol. 2025 Feb;79:103463. doi: 10.1016/j.redox.2024.103463. Epub 2024 Dec 9.
4
Loss of microRNA-15a/16-1 function promotes neuropathological and functional recovery in experimental traumatic brain injury.miR-15a/16-1 缺失促进实验性创伤性脑损伤的神经病理学和功能恢复。
JCI Insight. 2024 Jun 24;9(12):e178650. doi: 10.1172/jci.insight.178650.
5
MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line.在多发性硬化症中失调的微小RNA影响少突胶质细胞祖细胞系CG-4细胞的分化。
Front Cell Neurosci. 2024 Feb 29;18:1336439. doi: 10.3389/fncel.2024.1336439. eCollection 2024.
6
Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients.克拉屈滨和奥瑞珠单抗诱导复发缓解型多发性硬化患者外周血单个核细胞中差异的 miRNA 谱。
Front Immunol. 2023 Dec 13;14:1234869. doi: 10.3389/fimmu.2023.1234869. eCollection 2023.
7
In silico prioritisation of microRNA-associated common variants in multiple sclerosis.基于计算的多发性硬化症中 miRNA 相关常见变异的优先级排序。
Hum Genomics. 2023 Mar 30;17(1):31. doi: 10.1186/s40246-023-00478-4.
8
Impact of the Voltage-Gated Calcium Channel Antagonist Nimodipine on the Development of Oligodendrocyte Precursor Cells.电压门控钙通道拮抗剂尼莫地平对少突胶质前体细胞发育的影响。
Int J Mol Sci. 2023 Feb 13;24(4):3716. doi: 10.3390/ijms24043716.
9
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.原发性进行性多发性硬化症患者脑脊液中的 miRNA 特征。
Neurol Neuroimmunol Neuroinflamm. 2022 Dec 9;10(1). doi: 10.1212/NXI.0000000000200069. Print 2023 Jan.
10
Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.新发现的多发性硬化症中枢神经系统缺陷及其对髓鞘再生失败的影响。
Biomedicines. 2022 Mar 30;10(4):815. doi: 10.3390/biomedicines10040815.